Overview This page contains the latest trade data of Unpackaged Medicaments. In 2023, Unpackaged Medicaments were the world's 226th most traded product, with a total trade of $17.6B. Between 2022 and 2023 the exports of Unpackaged Medicaments grew by 44.7%, from $12.2B to $17.6B. Trade in Unpackaged Medicaments represent 0.078% of total world trade.
Unpackaged Medicaments are a part of Pharmaceutical products. They include Medicaments nes, formulated, in bulk, Antibiotics nes, formulated, in bulk, Hormones nes, no antibiotics, bulk, not contraceptive, Penicillins or streptomycins and derivatives, in bulk, Alkaloid derivatives (excluding antibiotics and hormones, in bulk), and Insulin, formulated, in bulk.
Exports In 2023 the top exporters of Unpackaged Medicaments were Ireland ($3.03B), Portugal ($2.97B), United States ($2.92B), China ($880M), and Germany ($777M).
Imports In 2023 the top importers of Unpackaged Medicaments were Belgium ($3.73B), United States ($2.15B), Canada ($1.87B), Germany ($1.69B), and Ireland ($689M).
Ranking Unpackaged Medicaments ranks 370th in the Product Complexity Index (PCI).
Description Examples of medicaments consisting of two or more constituents mixed together for therapeutic or prophylactic uses are antibiotics, which are used to treat bacterial infections, and vaccines, which are used to prevent diseases.